Janssen-Cilag A.G., Switzerland clinical trials
A country office of Johnson & Johnson
The registry lists 2 studies whose lead sponsor is Janssen-Cilag A.G., Switzerland. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jun 12, 2026.
Registry sponsor names on this page
- Janssen-Cilag A.G., Switzerland2 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Johnson & Johnson studies →
- A Study to Assess Real-world Outcomes for Long-Term Use of GuselkumabRecruitingNCT07532213
Sponsor listed in the registry: Janssen-Cilag A.G., Switzerland
- Comparison of Two Dosage Strengths of Transdermal Fentanyl Versus Transdermal Buprenorphine and Placebo in Acute Pain Models in Healthy Volunteers.CompletedNCT00886002Phase 1
Sponsor listed in the registry: Janssen-Cilag A.G., Switzerland